Axillary pathologic complete response after neoadjuvant systemic therapy by breast cancer subtype in patients with initially clinically node-positive disease: a …

S Samiei, JM Simons, SME Engelen… - JAMA …, 2021 - jamanetwork.com
Importance An overview of rates of axillary pathologic complete response (pCR) for all
breast cancer subtypes, both for patients with and without pathologically proven clinically …

Surgical management of the axilla in clinically node-positive breast cancer patients converting to clinical node negativity through neoadjuvant chemotherapy: current …

M Banys-Paluchowski, ML Gasparri, J de Boniface… - Cancers, 2021 - mdpi.com
Simple Summary Currently, it is unclear which kind of axillary staging surgery breast cancer
patients with lymph node metastasis should receive after neoadjuvant chemotherapy. For …

Diagnostic accuracy of different surgical procedures for axillary staging after neoadjuvant systemic therapy in node-positive breast cancer: a systematic review and …

JM Simons, TJA van Nijnatten, CC van der Pol… - Annals of …, 2019 - journals.lww.com
Objective: The aim of this study was to perform a systematic review and meta-analysis to
assess the accuracy of different surgical axillary staging procedures compared with ALND …

The evolving role of marked lymph node biopsy (MLNB) and targeted axillary dissection (TAD) after neoadjuvant chemotherapy (NACT) for node-positive breast …

PK Swarnkar, S Tayeh, MJ Michell, K Mokbel - Cancers, 2021 - mdpi.com
Simple Summary The 5-year survival rate for patients with breast cancer, in whom disease
has spread to local lymph nodes, is 85%. However, many live with the complications of …

Diagnostic accuracy of radioactive iodine seed placement in the axilla with sentinel lymph node biopsy after neoadjuvant chemotherapy in node-positive breast …

JM Simons, TJA Van Nijnatten, CC Van Der Pol… - JAMA …, 2022 - jamanetwork.com
Importance Several less-invasive staging procedures have been proposed to replace
axillary lymph node dissection (ALND) after neoadjuvant chemotherapy (NAC) in patients …

Three-year follow-up of de-escalated axillary treatment after neoadjuvant systemic therapy in clinically node-positive breast cancer: the MARI-protocol

AA van Loevezijn, MEM van der Noordaa… - Breast cancer research …, 2022 - Springer
Purpose In clinically node-positive (cN+) breast cancer patients, evidence supporting
response-guided treatment after neoadjuvant systemic therapy (NST) instead of axillary …

[HTML][HTML] De-escalating axillary surgery in early-stage breast cancer

EH Hersh, TA King - The Breast, 2022 - Elsevier
The role of axillary surgery has evolved over the last three decades from routine axillary
lymph node dissection (ALND) to sentinel lymph node biopsy to omission of axillary surgery …

Diagnostic performance of noninvasive imaging for assessment of axillary response after neoadjuvant systemic therapy in clinically node-positive breast cancer: a …

S Samiei, CM de Mooij, MBI Lobbes… - Annals of …, 2021 - journals.lww.com
Objective: The purpose of this study was to perform a systematic review and meta-analysis
to determine the diagnostic performance of current noninvasive imaging modalities for …

Correlation between pathologic complete response in the breast and absence of axillary lymph node metastases after neoadjuvant systemic therapy

S Samiei, TJA van Nijnatten, L de Munck… - Annals of …, 2020 - journals.lww.com
Objective: The aim was to investigate whether pathologic complete response (pCR) in the
breast is correlated with absence of axillary lymph node metastases at final pathology …

The Lucerne Toolbox 2 to optimise axillary management for early breast cancer: a multidisciplinary expert consensus

O Kaidar-Person, A Pfob, OD Gentilini, B Borisch… - …, 2023 - thelancet.com
Clinical axillary lymph node management in early breast cancer has evolved from being
merely an aspect of surgical management and now includes the entire multidisciplinary …